Abbott Laboratories buy Royal Bank of Canada
Start price
19.04.24
/
50%
€98.67
Target price
19.04.25
€117.41
Performance (%)
5.28%
Price
03.09.24
€103.88
Summary
This prediction is currently active. With a performance of 5.28%, the BUY prediction by Royal_Bank_of_Canada for Abbott Laboratories is trending in the right direction. This prediction currently runs until 19.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 2.689% | 2.689% |
iShares Core DAX® | -0.372% | 5.236% |
iShares Nasdaq 100 | -1.950% | 1.680% |
iShares Nikkei 225® | -1.690% | 7.286% |
iShares S&P 500 | -0.399% | 2.379% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€94.80
04.06.24
04.06.24
€114.98
04.06.25
04.06.25
9.58%
03.09.24
03.09.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
0.23%
03.09.24
03.09.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
1.81%
03.09.24
03.09.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
1.86%
03.09.24
03.09.24